Author/Authors
Ayyildiz, Talat Ondokuz Mayis University - Faculty of Medicine - Department of Gastroenterology, Turkey , Aydin, Taner Uludag University - Faculty of Medicine - Department of Internal Medicine, Turkey , Eminler, Ahmet Tarik Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Yildirim, Cinar Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Irak, Kader Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Kiyici, Murat Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Gurel, Selim Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Nak, Selim Giray Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Gulten, Macit Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey , Dolar, Enver Uludag University - Faculty of Medicine - Department of Gastroenterology, Turkey
Title Of Article
Sorafenib-induced pancreatitis
شماره ركورد
38220
Abstract
Sorafenib is an inhibitor of multikinase proteins which is used for metastaticrenal cell carcinoma and advanced stage hepatocellular carcinoma. Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. Five cases of acute pancreatitis have been reported in literature until date. The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
From Page
133
NaturalLanguageKeyword
Hepatocellular carcinoma , Pancreatitis , Sorafenib , Tyrosine kinase inhibitor
JournalTitle
Journal Of Experimental and Clinical Medicine
To Page
135
JournalTitle
Journal Of Experimental and Clinical Medicine
Link To Document